Plasma interleukin-6 is associated with coagulation in poorly controlled patients with type 2 diabetes

被引：0
|
作者：
Aso, Y
Okumura, KI
Kanda, T
Kobayshi, I
Takemura, Y
Inukai, T
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2466
引用
收藏
页码：A595 / A595
页数：1
相关论文
共 50 条
  • [31] Lipoperoxidation and antioxidant capacity in patients with poorly controlled type 2 diabetes
    Lodovici, M.
    Bigagli, E.
    Bardini, G.
    Rotella, C. M.
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2009, 25 (4-5) : 337 - 341
  • [32] Factors that influence improvement for patients with poorly controlled type 2 diabetes
    Hartz, Arthur
    Kent, Sarah
    James, Paul
    Xu, Yinghui
    Kelly, Michael
    Daly, Jeanette
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 (03) : 227 - 232
  • [33] Rosiglitazone is effective in poorly controlled type 2 diabetes patients.
    Goldstein, B
    Salzman, A
    DIABETOLOGIA, 1999, 42 : A229 - A229
  • [34] Short-term training effect of aerobic exercise on plasma interleukin-6 levels in type 2 diabetes
    Motoyama, K
    Yokoyama, H
    Mori, K
    Emoto, M
    Araki, T
    Teramura, M
    Koyama, H
    Shoji, T
    Nishizawa, Y
    DIABETES, 2005, 54 : A266 - A266
  • [35] SEX DIFFERENCES IN INTERLEUKIN-6 STRESS RESPONSES IN PEOPLE WITH TYPE 2 DIABETES
    Panagi, Laura
    Poole, Lydia
    Hackett, Ruth A.
    Steptoe, Andrew
    PSYCHOSOMATIC MEDICINE, 2019, 81 (04): : A127 - A127
  • [36] Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus
    Rehman, Kanwal
    Akash, Muhammad Sajid Hamid
    Liaqat, Aamira
    Kamal, Shagufta
    Qadir, Muhammad Imran
    Rasul, Akhtar
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2017, 27 (03): : 229 - 236
  • [37] Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
    Koshino, Akihiko
    Schechter, Meir
    Sen, Taha
    Vart, Priya
    Neuen, Brendon L.
    Neal, Bruce
    Arnott, Clare
    Perkovic, Vlado
    Ridker, Paul M.
    Tuttle, Katherine R.
    Hansen, Michael K.
    Heerspink, Hiddo J. L.
    DIABETES CARE, 2022, 45 (11) : 2644 - 2652
  • [38] The effect of treatment with rosiglitazone on C-reactive protein and interleukin-6 in patients with type 2 diabetes
    Fuell, DL
    Freed, MI
    Greenberg, AS
    Haffner, S
    Chen, HZ
    DIABETES, 2001, 50 : A435 - A435
  • [39] Interleukin-6 and Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Post Hoc Analysis of CANVAS Trial
    Koshino, Akihiko
    Schechter, Meir
    Sen, Taha
    Neuen, Brendon
    Arnott, Clare
    Perkovic, Vlado
    Hansen, Michael K.
    Heerspink, Hiddo L.
    DIABETES, 2022, 71
  • [40] Sex differences in interleukin-6 stress responses in people with Type 2 diabetes
    Panagi, Laura
    Poole, Lydia
    Hackett, Ruth A.
    Steptoe, Andrew
    PSYCHOPHYSIOLOGY, 2019, 56 (06)
12345